MedPath

The role of dopamine in visuospatial attention.

Conditions
Methylphenidate, frequently prescribed in the treatment of ADHD, increases the central availability of both dopamine and noradrenaline. The roles of dopamine and noradrenaline in attention and inhibition are yet unclear. It is of importance to investigate the role of these neurotransmitter systems since at least 20 percent of patients do not benefit from methylphenidate or have undesired side effects.
Registration Number
NL-OMON26886
Lead Sponsor
trecht University
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
38
Inclusion Criteria

1. Age 18 – 45;

2. Male.

Exclusion Criteria

Any of the following (assessed by interview):

1. History of cardiovascular problems;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath